Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06884579

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)

This phase of the project aims to compare in-person, supervised educational programs (EP) with online self-guided EPs in individuals with relapsing-remitting multiple sclerosis. A total of 75 participants will be randomly assigned to one of three groups: a supervised and individualized educational program focused on HIIT training, a supervised and individualized educational program focused on strength training, and a non-supervised, self-guided educational program based on resistance band training. Additionally, sessions on the Mediterranean diet (both supervised and non-supervised) and cognitive-behavioral interventions will be included. A control evaluation will be conducted three months after the intervention to assess the effects of the educational programs, followed by another evaluation three months later to analyze residual effects. Women who participated in Phase 1 of the study will be invited to take part in this second phase.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

include:

  • Women and men of reproductive age (18-45 years) with MS will be included, with the upper age limit adjusted to reflect the reproductive phase;
  • no iron-deficiency anemia;
  • stable disease phase;
  • independent walking ability for over 10 meters.

Women will be recruited first and later matched with men based on age, EDSS, and lifestyle habits (physical activity, smoking, and alcohol consumption).

Exclusion criteria

will include participants with MS who:

  • score <1 or >6 on the EDSS;
  • report a relapse within 12 months before the study begins;
  • have taken corticosteroid treatment within the last 2 months;
  • have participated in a structured training program in the previous 6 months.

Once all women with MS are recruited, male participants will be recruited following a 1:1 matching methodology based on age, geographic region, and lifestyle habits.

Treatment and study plan

Strength training, nutrition, and behavioral training

Other

This arm of the study consists of a supervised strength training program, conducted over 12 weeks with three weekly sessions. The sessions follow a wave-like periodization, with intensities ranging from 70% to 85% of 1-RM. Exercises focus on enhancing neuromuscular strength in the lower limbs, such as leg presses and hip extensions, under the supervision of a multidisciplinary team.

Participants will also receive nutritional guidance based on the Mediterranean diet, as well as cognitive-behavioral therapy strategies aimed at optimizing fatigue management and boosting energy levels.

Self-Guided and Unsupervised Program with General Recommendations

Other

This arm of the study consists of a self-guided and unsupervised program based on physical exercise (3 times per week), nutrition, and cognitive-behavioral habits. Participants will access online modules that provide guidelines for performing resistance exercises with bands, dietary recommendations following the principles of the Mediterranean diet, and cognitive-behavioral techniques for fatigue management.

Primary outcomes

  1. Satisfaction with Physical Activity

    Time frame: Baseline (pre-intervention)

    Satisfaction with Physical Activity will be measured using an eight-item, 5-point Likert scale

  2. Satisfaction with Physical Activity

    Time frame: Immediately after the intervention

    Satisfaction with Physical Activity will be measured using an eight-item, 5-point Likert scale

  3. Visual Analogue Scale for Fatigue (VAS-F)

    Time frame: Immediately before each of the 36 exercise sessions (pre-session assessment).

    The Visual Analogue Scale for Fatigue (VAS-F) assesses subjective levels of fatigue and energy

  4. Visual Analogue Scale for Fatigue (VAS-F)

    Time frame: Immediately after each of the 36 exercise sessions (post-session assessment).

    The Visual Analogue Scale for Fatigue (VAS-F) assesses subjective levels of fatigue and energy

  5. Modified Fatigue Impact Scale (MFIS)

    Time frame: Baseline (pre-intervention).

    Fatigue perception will be measured using the MFIS. This scale is a 21-item multidimensional questionnaire that evaluates the physical, cognitive, and psychosocial effects of fatigue on a five-point ordinal scale (with a maximum total score of 84).

  6. Modified Fatigue Impact Scale (MFIS)

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Fatigue perception will be measured using the MFIS. This scale is a 21-item multidimensional questionnaire that evaluates the physical, cognitive, and psychosocial effects of fatigue on a five-point ordinal scale (with a maximum total score of 84)

Secondary outcomes

  1. Inflammatory Profile

    Time frame: Baseline (pre-intervention).

    The inflammatory profile evaluates key cytokines, including IFN-γ, IL-6, TNF-α, IL-10, and TGF-β1, to assess systemic inflammation and immune response dynamics

  2. Inflammatory Profile

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The inflammatory profile evaluates key cytokines, including IFN-γ, IL-6, TNF-α, IL-10, and TGF-β1, to assess systemic inflammation and immune response dynamics

  3. The hormonal profile

    Time frame: Pre-intervention in each phase of the menstrual cycle (early follicular phase, late follicular phase and mid-luteal phase).

    The hormonal profile includes the assessment of TSH, progesterone (PG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, and testosterone to evaluate endocrine function, menstrual cycle phases, and hormonal balance.

  4. Cognitive Function

    Time frame: Baseline (pre-intervention).

    Brain-Derived Neurotrophic Factor (BDNF) is a protein involved in neuroplasticity, cognitive function, and neuronal survival, serving as a blood biomarker for brain health and adaptability.

  5. Cognitive Function

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Brain-Derived Neurotrophic Factor (BDNF) is a protein involved in neuroplasticity, cognitive function, and neuronal survival, serving as a blood biomarker for brain health and adaptability

  6. Neurofilament Light Chain (NFL)

    Time frame: Baseline (pre-intervention).

    Neurofilament light chain (NFL) is one of the most relevant biomarkers in multiple sclerosis (MS). The Simoa detection technique (ultrasensitive single-molecule array) allows its analysis in serum, providing both the total value and the Z-Score, enabling precise assessment of axonal damage and disease progression.

  7. Neurofilament Light Chain (NFL)

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Neurofilament light chain (NFL) is one of the most relevant biomarkers in multiple sclerosis (MS). The Simoa detection technique (ultrasensitive single-molecule array) allows its analysis in serum, providing both the total value and the Z-Score, enabling precise assessment of axonal damage and disease progression.

  8. Physical Self-Perception

    Time frame: Baseline (pre-intervention).

    Physical self-perception will be evaluated using six subscales-sports competence, physical condition, body attractiveness, physical strength, general physical self-perception, and overall self-perception-on a 5-point Likert scale

  9. Physical Self-Perception

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Physical self-perception will be evaluated using six subscales-sports competence, physical condition, body attractiveness, physical strength, general physical self-perception, and overall self-perception-on a 5-point Likert scale

  10. Walking Endurance

    Time frame: Baseline (pre-intervention).

    Participants will undergo the 2-minute walk test, during which they will walk at their preferred, self-selected speed to assess walking endurance. The test course will be rectangular, with corners marked by cones. Participants will be allowed to rest during the test, if necessary, but the clock will not stop during these rest periods. The total distance covered will be recorded

  11. Walking Endurance

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Participants will undergo the 2-minute walk test, during which they will walk at their preferred, self-selected speed to assess walking endurance. The test course will be rectangular, with corners marked by cones. Participants will be allowed to rest during the test, if necessary, but the clock will not stop during these rest periods. The total distance covered will be recorded

  12. Pain Catastrophizing

    Time frame: Baseline (pre-intervention).

    The Pain Catastrophizing Scale will measure catastrophic thoughts related to pain, focusing on rumination and helplessness, with responses on a similar scale

  13. Pain Catastrophizing

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The Pain Catastrophizing Scale will measure catastrophic thoughts related to pain, focusing on rumination and helplessness, with responses on a similar scale

  14. Quality of Life questionnaire

    Time frame: Baseline (pre-intervention).

    The Multiple Sclerosis Quality of Life-54 will gauge quality of life across 14 subscales, yielding physical and mental health composite scores

  15. Quality of Life questionnaire

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The Multiple Sclerosis Quality of Life-54 will gauge quality of life across 14 subscales, yielding physical and mental health composite scores

  16. State-Trait Anxiety

    Time frame: Baseline (pre-intervention).

    Description: The State-Trait Anxiety Inventory will measure both situational and general anxiety on a 4-point scale

  17. State-Trait Anxiety

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The State-Trait Anxiety Inventory will measure both situational and general anxiety on a 4-point scaleTime Frame: Before the first training session

  18. Rate of force development

    Time frame: Baseline (pre-intervention).

    Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway). They will perform three maximum contractions, each lasting 2 seconds, with 3 minutes of rest in between. The RFD will be analyzed. Testing will begin with the right leg, and the repetition with the highest recorded value for each leg will be used in the analysis

  19. Rate of force development

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway). They will perform three maximum contractions, each lasting 2 seconds, with 3 minutes of rest in between. The RFD will be analyzed. Testing will begin with the right leg, and the repetition with the highest recorded value for each leg will be used in the analysis

  20. Maximum Voluntary Isometric Contraction

    Time frame: Baseline (pre-intervention).

    Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway).Participants will perform three 5-second MVIC, with 3 minutes of rest in between. Testing will always begin with the right leg, and the contraction with the highest recorded MVIC value will be used in the analysis Time Frame: Before the first training session

  21. Maximum Voluntary Isometric Contraction

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Participants will sit in a chair with both legs flexed at a 90-degree angle, and the tested ankle securely attached to a customized device with a load cell (MuscleLab Force Sensor, Ergotest AS, Langesund, Norway).Participants will perform three 5-second MVIC, with 3 minutes of rest in between. Testing will always begin with the right leg, and the contraction with the highest recorded MVIC value will be used in the analysis Time Frame: Before the first training session

  22. Maximal neural drive

    Time frame: Baseline (pre-intervention).

    To measure neural drive, the electromyographic activity (sEMG) of the right leg's vastus lateralis will be recorded during the MVIC (Delsys Trigno, Delsys Inc., Boston, MA) with skin prepared and electrode positioning following SENIAM guidelines. EMG peak will be analyzed. The EMG peak during MVIC will represent the maximum neural drive

  23. Maximal neural drive

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    To measure neural drive, the electromyographic activity (sEMG) of the right leg's vastus lateralis will be recorded during the MVIC (Delsys Trigno, Delsys Inc., Boston, MA) with skin prepared and electrode positioning following SENIAM guidelines. EMG peak will be analyzed. The EMG peak during MVIC will represent the maximum neural drive

  24. Central activation ratio

    Time frame: Baseline (pre-intervention).

    Two bipolar electrodes (10×15 cm) will be placed on the right quadriceps, with electrical stimulation controlled by Signal 6.0 software (CED, Cambridge, England) at 100 Hz frequency, 50 pulses, 0.009 s pulse duration, and 0.01 s interval, set to 40-50% of MVIC. Central activation ratio (CAR) will be assessed through a sequence of one supramaximal twitch, a 100 Hz tetanic train, an MVIC with superimposed tetanic train, followed by a potentiated tetanic train and a potentiated supramaximal twitch. This sequence will be repeated twice with 2-minute rests, and twitch-to-tetanus ratio, MVIC peak, and maximum force values will be calculated for CAR. The CAR will be calculated using the following formula: "CAR= " "Force during MVIC" /"Force during MVIC + supramaximal stimulation"

  25. Central activation ratio

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Two bipolar electrodes (10×15 cm) will be placed on the right quadriceps, with electrical stimulation controlled by Signal 6.0 software (CED, Cambridge, England) at 100 Hz frequency, 50 pulses, 0.009 s pulse duration, and 0.01 s interval, set to 40-50% of MVIC. Central activation ratio (CAR) will be assessed through a sequence of one supramaximal twitch, a 100 Hz tetanic train, an MVIC with superimposed tetanic train, followed by a potentiated tetanic train and a potentiated supramaximal twitch. This sequence will be repeated twice with 2-minute rests, and twitch-to-tetanus ratio, MVIC peak, and maximum force values will be calculated for CAR. The CAR will be calculated using the following formula: "CAR= " "Force during MVIC" /"Force during MVIC + supramaximal stimulation"

  26. Upper Limb Maximum Strength

    Time frame: Baseline (pre-intervention).

    Isometric grip strength will be measured with an electronic dynamometer (K-Force Grip, Kinvent, Montpellier, France) as participants stand with elbows extended. Each hand will perform 3 trials, with 30 seconds rest between attempts

  27. Upper Limb Maximum Strength

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Isometric grip strength will be measured with an electronic dynamometer (K-Force Grip, Kinvent, Montpellier, France) as participants stand with elbows extended. Each hand will perform 3 trials, with 30 seconds rest between attempts

  28. Spasticity

    Time frame: Before the first session of the intervention program

    The Pendulum Test is used to assess the level of spasticity by evaluating the resistance to passive movement in the affected limb. The test involves moving the limb in a pendulum-like motion and observing the fluidity of the movement, with increased resistance indicating higher spasticity levels

  29. Spasticity

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The Pendulum Test is used to assess the level of spasticity by evaluating the resistance to passive movement in the affected limb. The test involves moving the limb in a pendulum-like motion and observing the fluidity of the movement, with increased resistance indicating higher spasticity levels

  30. Intrinsic muscle characteristics

    Time frame: Baseline (pre-intervention).

    Muscle characteristics (frequency, stiffness, degradation) assessed with MyotonPRO (MyotonPRO, Myoton AS, Estonia)

  31. Intrinsic muscle characteristics

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Muscle characteristics (frequency, stiffness, degradation) assessed with MyotonPRO (MyotonPRO, Myoton AS, Estonia)

  32. Gait speed

    Time frame: Baseline (pre-intervention).

    Gait speed will be determined with the 10-meter walk test using two photocells (Ergotest Technology AS, Langesund, Norway) at 5 and 10 meters; participants will complete two maximum-speed trials, with the slower time recorded

  33. Gait speed

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Gait speed will be determined with the 10-meter walk test using two photocells (Ergotest Technology AS, Langesund, Norway) at 5 and 10 meters; participants will complete two maximum-speed trials, with the slower time recorded

  34. Static balance with eyes open

    Time frame: Baseline (pre-intervention).

    Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

  35. Static balance with eyes open

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

  36. Static balance with eyes closed

    Time frame: Baseline (pre-intervention).

    Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

  37. Static balance with eyes closed

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Balance is measured with static trials on a force platform (Ergotest Technology AS, Langesund, Norway), where participants stand barefoot with arms at their sides for two 30-second trials each

  38. Sit-to-stand

    Time frame: Baseline (pre-intervention).

    The sit-to-stand test requires participants to rise as quickly as possible from a seated position with 90º knee flexion and arms crossed

  39. Sit-to-stand

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The sit-to-stand test requires participants to rise as quickly as possible from a seated position with 90º knee flexion and arms crossed

  40. Timed Up-and-Go test

    Time frame: Baseline (pre-intervention).

    In the Timed Up-and-Go test, participants move from sitting to standing, walk 3 meters, turn, return, and sit

  41. Timed Up-and-Go test

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    In the Timed Up-and-Go test, participants move from sitting to standing, walk 3 meters, turn, return, and sit

  42. Delayed onset muscle soreness

    Time frame: Baseline (pre-intervention).

    To measure delayed onset muscle soreness (DOMS), a 10-point visual analogue scale shall be used, where 1 = no pain and 10 = intolerable pain

  43. Subjective Perception of Effort

    Time frame: Baseline (pre-intervention).

    Participants will be instructed and familiarized with the use of the RPE scale during the familiarization phase. RPE will be assessed before, during (after each exercise within the session), and after the training session using the Borg 6-20 RPE scale

  44. Fatigue Visual Analog Scale (VAS-F)

    Time frame: Baseline (pre-intervention).

    The VAS-F will be used to measure fatigue. This scale, is subdivided into two subscales: fatigue and energy. The VAS-F features a 100 mm long horizontal line, with the term "none" at one end and "very severe" at the opposite end. Participants are required to mark the point on the line corresponding to their perception of the severity of fatigue between these two endpoints.

  45. Anthropometric

    Time frame: Baseline (pre-intervention).

    Anthropometric measurements will be taken to assess body morphology, fat distribution, and potential alterations due to multiple sclerosis (MS), such as muscle atrophy or changes in body fat percentage. These measurements provide valuable information regarding comorbidities, including abdominal obesity and cardiovascular risk, which are particularly relevant in MS due to factors like reduced mobility or medication use

  46. Anthropometric

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Anthropometric measurements will be taken to assess body morphology, fat distribution, and potential alterations due to multiple sclerosis (MS), such as muscle atrophy or changes in body fat percentage. These measurements provide valuable information regarding comorbidities, including abdominal obesity and cardiovascular risk, which are particularly relevant in MS due to factors like reduced mobility or medication use

  47. Bioimpedance

    Time frame: Baseline (pre-intervention).

    Bioimpedance will be used to assess body composition, including body fat percentage, lean mass, and total body water. These measurements are important for understanding changes in body composition due to multiple sclerosis (MS), as the disease can impact muscle mass, fluid balance, and fat distribution. Bioimpedance provides valuable insight into the health status and nutritional needs of individuals with MS

  48. Bioimpedance

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Bioimpedance will be used to assess body composition, including body fat percentage, lean mass, and total body water. These measurements are important for understanding changes in body composition due to multiple sclerosis (MS), as the disease can impact muscle mass, fluid balance, and fat distribution. Bioimpedance provides valuable insight into the health status and nutritional needs of individuals with MS

  49. Physical Activity Levels

    Time frame: Baseline (pre-intervention).

    To assess physical activity in patients with multiple sclerosis (MS), both the International Physical Activity Questionnaire (IPAQ) and triaxial accelerometers can be adapted to account for the mobility limitations often experienced by these individuals. The IPAQ can be tailored by including questions that specifically address low-impact or moderate-intensity activities, considering factors such as fatigue and muscle weakness. Triaxial accelerometers, which measure movement in three planes (vertical, lateral, and anterior-posterior), provide a more detailed and precise measurement of physical activity, capturing even small movements or low-intensity activities such as walking short distances. Together, these tools allow for a comprehensive assessment of physical activity levels in MS patients, while considering their unique needs and capabilities. Additionally, the MET (Metabolic Equivalent of Task) methodology should be adjusted to reflect the lower intensity of activities commonly p

  50. Physical Activity Levels

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    To assess physical activity in patients with multiple sclerosis (MS), both the International Physical Activity Questionnaire (IPAQ) and triaxial accelerometers can be adapted to account for the mobility limitations often experienced by these individuals. The IPAQ can be tailored by including questions that specifically address low-impact or moderate-intensity activities, considering factors such as fatigue and muscle weakness. Triaxial accelerometers, which measure movement in three planes (vertical, lateral, and anterior-posterior), provide a more detailed and precise measurement of physical activity, capturing even small movements or low-intensity activities such as walking short distances. Together, these tools allow for a comprehensive assessment of physical activity levels in MS patients, while considering their unique needs and capabilities. Additionally, the MET (Metabolic Equivalent of Task) methodology should be adjusted to reflect the lower intensity of activities commonly p

  51. Dietary and Nutritional Follow-up

    Time frame: Baseline (pre-intervention).

    Mediterranean Diet adherence questionnaires and food diaries could be effective tools for evaluating nutrition, particularly if MS patients have poor consumption of essential nutrients for their overall health

  52. Dietary and Nutritional Follow-up

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Mediterranean Diet adherence questionnaires and food diaries could be effective tools for evaluating nutrition, particularly if MS patients have poor consumption of essential nutrients for their overall health

  53. The Kurtzke Disability Scale

    Time frame: Baseline (pre-intervention).

    The Kurtzke Disability Scale (EDSS) is divided into 8 functional systems (FS); four primary: pyramidal function, cerebellar function, sensory function, and brainstem function; and four secondary: sphincters, vision, mental, and others. For each FS, a severity score is provided, ranging from 0 to 6 or 7. The overall score of the scale is measured on a 20-item scale (from 0 to 10 points, increasing in half-point increments). Up to 3.5, the score obtained in each FS and the number of affected FS automatically determine the EDSS score. From 4 to 7, the definition of each level is also given by the ability to walk (ability to walk without stopping, need for assistance)

  54. The Kurtzke Disability Scale

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    The Kurtzke Disability Scale (EDSS) is divided into 8 functional systems (FS); four primary: pyramidal function, cerebellar function, sensory function, and brainstem function; and four secondary: sphincters, vision, mental, and others. For each FS, a severity score is provided, ranging from 0 to 6 or 7. The overall score of the scale is measured on a 20-item scale (from 0 to 10 points, increasing in half-point increments). Up to 3.5, the score obtained in each FS and the number of affected FS automatically determine the EDSS score. From 4 to 7, the definition of each level is also given by the ability to walk (ability to walk without stopping, need for assistance).

  55. Subjective Sleep Quality Questionnaire

    Time frame: Baseline (pre-intervention).

    Subjective sleep quality will be measured using the Karolinska Sleep Diary questionnaire [73]. The questionnaire includes the following items: a) sleep quality (very poor [1] - very good [5]), b) sleep tranquility (very restless [1] - very calm [5]), c) ease of falling asleep (very difficult [1] - very easy [5]), d) awakenings (woke up too early [1] - did not wake up early [3]), e) ease of waking up (very difficult [1] - very easy [5]), f) feeling of rest (did not rest at all [1] - fully rested [3]), and g) sufficient sleep (no, definitely too little [1] - yes, definitely enough [5]).

  56. Subjective Sleep Quality Questionnaire

    Time frame: 48 hours after the last exercise session (post-intervention assessment).

    Subjective sleep quality will be measured using the Karolinska Sleep Diary questionnaire [73]. The questionnaire includes the following items: a) sleep quality (very poor [1] - very good [5]), b) sleep tranquility (very restless [1] - very calm [5]), c) ease of falling asleep (very difficult [1] - very easy [5]), d) awakenings (woke up too early [1] - did not wake up early [3]), e) ease of waking up (very difficult [1] - very easy [5]), f) feeling of rest (did not rest at all [1] - fully rested [3]), and g) sufficient sleep (no, definitely too little [1] - yes, definitely enough [5]).

  57. Sleep Quality Measured by Actigraph

    Time frame: The week prior to the start of the intervention. Baseline (pre-intervention).

    Sleep quality based on actigraphy will be evaluated using the Actiwatch wGT3X-BT activity monitoring system (Cambridge Neurotechnology, Cambridge, UK) [74]. This device uses a piezoelectric accelerometer to measure activity. Participants will wear the Actiwatch on their non-dominant wrist. The lower sensitivity threshold for actigraphy will be set at 80 counts/epoch. Data analysis will begin at the start of the nighttime rest period (bedtime) and conclude at the start of daytime activity (wake-up time).

  58. Sleep Quality Measured by Actigraph

    Time frame: The week following the completion of the intervention (post-intervention assessment).

    Sleep quality based on actigraphy will be evaluated using the Actiwatch wGT3X-BT activity monitoring system (Cambridge Neurotechnology, Cambridge, UK) [74]. This device uses a piezoelectric accelerometer to measure activity. Participants will wear the Actiwatch on their non-dominant wrist. The lower sensitivity threshold for actigraphy will be set at 80 counts/epoch. Data analysis will begin at the start of the nighttime rest period (bedtime) and conclude at the start of daytime activity (wake-up time)

  59. Delayed onset muscle soreness

    Time frame: Immediately after each physical exercise session (post-intervention assessment).

    To measure delayed onset muscle soreness (DOMS), a 10-point visual analogue scale shall be used, where 1 = no pain and 10 = intolerable pain

  60. Subjective Perception of Effort

    Time frame: Immediately after each physical exercise session (post-intervention assessment).

    Participants will be instructed and familiarized with the use of the RPE scale during the familiarization phase. RPE will be assessed before, during (after each exercise within the session), and after the training session using the Borg 6-20 RPE scale

  61. Fatigue Visual Analog Scale (VAS-F)

    Time frame: Immediately after each physical exercise session (post-intervention assessment).

    The VAS-F will be used to measure fatigue. This scale, is subdivided into two subscales: fatigue and energy. The VAS-F features a 100 mm long horizontal line, with the term "none" at one end and "very severe" at the opposite end. Participants are required to mark the point on the line corresponding to their perception of the severity of fatigue between these two endpoints.

Sponsors and collaborators

Lead sponsor

Universidad de Almeria

Other

Collaborators

  • Hospital Universitario Virgen de la Arrixaca

Registry information

Official study title

Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: The ADVICE Protocol Study

Acronym: ADVICE Phase 2

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Mar 19, 2025
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.